Chemotherapy-Related Toxicities In Ovarian Cancer Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00508378|
Recruitment Status : Active, not recruiting
First Posted : July 30, 2007
Last Update Posted : October 25, 2017
To assess the preferences of women with ovarian cancer, their clinical caregivers, familial caregivers, and a control group for toxicities associated with chemotherapy.
- To compare preferences of women with ovarian cancer to preferences of their clinical caregivers.
- To compare preferences of women with ovarian cancer to preferences of their familial caregivers.
- To compare preferences of women with ovarian cancer to preferences of a women in the control group.
- To prospectively collect quality of life data from women with ovarian cancer.
- To prospectively collect symptom assessment data from women with ovarian cancer.
|Condition or disease||Intervention/treatment|
|Ovarian Cancer||Behavioral: Interview Behavioral: Questionnaire|
Patients in this study will be recruited from the Gynecologic Oncology Clinic waiting area. All participants (patients, family and clinical caregivers, control group women with no cancer) in this study will take part in an interview to see how they feel about the different side-effects of chemotherapy. The interview will involve reading short descriptions of the side-effects and then answering some questions that ask for an opinion. The actual interview will take about 30-45 minutes to complete. The interviews will either take place in private conference rooms in the clinic or in private rooms at the Ambulatory Treatment Center (ATC).
Patients will also be given quality of life and symptom assessment questionnaires. The questionnaires are simple to read and quick to answer. The questionnaire takes about 15 minutes to complete.
The participant's involvement in this study is limited to the questionnaire/interview. Once that is done, the participant is finished with the study.
This is an investigational study. A total of 288 people will take part in this study. All will be enrolled at M. D. Anderson.
|Study Type :||Observational|
|Estimated Enrollment :||288 participants|
|Official Title:||Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life|
|Actual Study Start Date :||January 2001|
|Estimated Primary Completion Date :||January 2020|
|Estimated Study Completion Date :||January 2020|
|Interview & Questionnaires||
Interview regarding side-effects of chemotherapy, 30-45 minutes.
Other Name: SurveyBehavioral: Questionnaire
Quality of life survey and symptom assessment questionnaire, 15 minutes.
- Qualitative information on how ovarian cancer patients, their family members, and doctors and nurses feel about the side-effects of chemotherapy. [ Time Frame: 8 Years ]
- Patient Response to Quality of Life Using Interview + Questionnaire [ Time Frame: 30 minute interviews + 15 minutes for questionnaire ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00508378
|United States, Texas|
|University of Texas MD Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Diane C. Bodurka, MD||M.D. Anderson Cancer Center|